Gérald Voss - Concepedia

Author

Gérald Voss

GlaxoSmithKline (Belgium)ORCID

Also Known As

Bar, Katharine J., G VOSS, G Voss, G. Voss, GERALD VOSS, Gerald Voss, Gérald Voss, LAURENCE VIGNERON, Voss, Gerald H.

104

Publications

6.5K

Citations

H-Index

Concepts

All Affiliations

GlaxoSmithKline (Belgium)German Primate Center GlaxoSmithKline (United Kingdom)Walter Reed Army Institute of Research Harvard University

About

Gérald Voss is an author at GlaxoSmithKline (Belgium) specializing in immunology, medicine, and vaccination.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	26	38	4.3K
2	Immunology	26	38	4.3K
3	Allergy	5	5	1.3K
4	Cell Biology	5	5	508
5	Biomolecular Engineering	1	1	117

Gérald Voss

Publications

6.2K

Citations

H-Index

Page 1

	Year	Citations
Human Immunodeficiency Virus Type 1<i>env</i>Clones from Acute and Early Subtype B Infections for Standardized Assessments of Vaccine-Elicited Neutralizing Antibodies Ming Li, Feng Gao, John R. Mascola, Journal of Virology Vaccine-elicited Neutralizing AntibodiesStandardized AssessmentsImmunodeficienciesImmunologyImmunotherapy	2005	1.1K
Efficacy of RTS,S/AS02 malaria vaccine against Plasmodium falciparum infection in semi-immune adult men in The Gambia: a randomised trial Kalifa Bojang, Paul Milligan, Margaret Pinder, The Lancet VaccinationPlasmodium Falciparum InfectionRandomised TrialMalariaImmunology	2001	526
Protective efficacy of adenovirus/protein vaccines against SIV challenges in rhesus monkeys Dan H. Barouch, Galit Alter, Thomas Broge, Science VaccinationVaccine SafetyProtective EfficacyVaccine DevelopmentRhesus Monkeys	2015	290
Efficacy of Recombinant Circumsporozoite Protein Vaccine Regimens against Experimental<i>Plasmodium falciparum</i>Malaria Kent E. Kester, Denise McKinney, Nadia Tornieporth, The Journal of Infectious Diseases	2001	270
A CD4+ T-cell immune response to a conserved epitope in the circumsporozoite protein correlates with protection from natural Plasmodium falciparum infection and disease William H. H. Reece, Margaret Pinder, Philip Gothard, Nature Medicine MalariaImmunologyAntigen ProcessingAutoimmunityCd4 T Cell Responses	2004	263
An env gene derived from a primary human immunodeficiency virus type 1 isolate confers high in vivo replicative capacity to a chimeric simian/human immunodeficiency virus in rhesus monkeys Keith A. Reimann, J T Li, Gérald Voss, Journal of Virology Viral ReplicationViral PersistenceRhesus MonkeysHuman RetrovirusPathogenesis	1996	235
Protective Immunity Induced with Malaria Vaccine, RTS,S, Is Linked to <i>Plasmodium falciparum</i> Circumsporozoite Protein-Specific CD4+ and CD8+ T Cells Producing IFN-γ Peifang Sun, Robert Schwenk, Katherine White, The Journal of Immunology	2003	231
Initial antibodies binding to HIV-1 gp41 in acutely infected subjects are polyreactive and highly mutated Hua‐Xin Liao, Xi Chen, Supriya Munshaw, The Journal of Experimental Medicine	2011	208
An evaluation of dengue type-2 inactivated, recombinant subunit, and live-attenuated vaccine candidates in the rhesus macaque model J. Robert Putnak, Beth-Ann Coller, Gérald Voss, Vaccine VaccinationRecombinant SubunitVaccine DevelopmentVaccine TargetImmunology	2005	168
Characterization of Antibody Responses Elicited by Human Immunodeficiency Virus Type 1 Primary Isolate Trimeric and Monomeric Envelope Glycoproteins in Selected Adjuvants Y. Li, Krisha Svehla, Nathalie Mathy, Journal of Virology ImmunologyYu2 Gp140 TrimersHiv-1 IsolatesImmunotherapyHuman Retrovirus	2006	159

Page 1